Why BioNTech Stock Is Jumping Again Today
_0.png?locale=de){kind=logo}
Shares of BioNTech (NASDAQ: BNTX) were jumping 5.5% at 10:17 a.m. EDT on Wednesday. This marked the second consecutive day of nice gains for the stock. The German biotech reported great fourth-quarter results yesterday. Today's move was due to BioNTech's and Pfizer's (NYSE: PFE) announcement of results from a late-stage study of COVID-19 vaccine BNT162b2 in children ages 12 to 15.
You couldn't ask for better news from BioNTech's and Pfizer's clinical update. The two companies reported that BNT162b2 demonstrated 100% efficacy along with robust antibody responses in kids ages 12 to 15. This is even higher than the earlier high efficacy levels achieved by the vaccine in older age groups.
BioNTech and Pfizer also stated that BNT162b2 was well tolerated by the children participating in the late-stage study. The companies noted that side effects were "generally consistent with those observed in participants 16 to 25 years of age."
Source Fool.com
